Q4 2020 Affimed NV Earnings Call Transcript
Good day, everyone, and welcome to Affimed's Fourth Quarter and Year-end 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions). As a reminder, today's conference call is being recorded.
I would now like to introduce your host for today, Mr. Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Thank you, Tracy. I'd like to welcome and thank you all for joining us today for Affimed's Fourth Quarter and 2020 Year-end Financial Results and Operational Update Call.
Before we begin, I'd like to remind everyone that we issued our release earlier today and it can be found on our Investor Relations section of our website. On the call today, we have our management team, doctors, Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; and then Ms. Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |